Replies to post #235791 on Biotech Values

[vinmantoo]

CRDF’s Onvansertib is a small molecule PLK1 inhibitor. Came from Pfizer Italia (currently Nerviano
Medical Sciences) which also developed small molecule blockbusters for Array (recently acquired by Pfizer), Ignyta
(acquired by Roche) and Genentech.

KZIA updated by Edison Research

https://kza.irmau.com/irm/PDF/8b64300e-5cf8-4d7a-8382-81ffc7bf909f/EdisonResearchPhaseIIashowsgoodsafetyconsistentefficacy

Bladerunner

xavierprivas and bladerunner,

Thanks for taking he time to give an overview. I will take a closer look.